Remove Eating disorders Remove Healthcare Remove Manufacturing
article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur. Clinical trials reveal higher plasma exposure and adverse effects in younger children, questioning the benefit-risk balance of these medications.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

Moynihan’s research and writing focus on the healthcare industry, with an emphasis on how diseases are created, branded, and marketed to unsuspecting people. He is known for his use of sharp humor, which can be seen in his mock documentary about a fictional illness called ‘Motivational Deficiency Disorder.’